Cargando…

MON-162 Utility of 24-Hour Urine Cortisone for the Diagnosis of Cushing’s Syndrome

Background: Obesity, diabetes and hypertension are common in the general population, and do not discriminate between patients (pts) with or without Cushing’s syndrome (CS). Thus, Endocrine Society guidelines recommend biochemical testing in pts with multiple features compatible with the diagnosis (1...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGlotten, Raven, Paul, Namrata, Soldin, Steven, Nieman, Lynnette K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207746/ http://dx.doi.org/10.1210/jendso/bvaa046.1438

Ejemplares similares

MON-178 Cyclical Cushing’s Syndrome in 12 Patients with Ectopic ACTH Secretion
por: Zenno, Anna, et al.
Publicado: (2020)

MON-167 Use of a Morning Cortisol Level to Predict Recovery of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in Secondary Adrenal Insufficiency Following Remission of Cushing’s Syndrome
por: McGlotten, Raven, et al.
Publicado: (2020)

SUN-368 Fatty Hypertrophy of the Hip as a Clinical Manifestation of Cushing Syndrome
por: McGlotten, Raven, et al.
Publicado: (2019)

MON-182 Increased Risk of Bleeding and Excessive Anticoagulation Using Standard Dose Low Molecular Weight Heparin (LMWH) in Cushing’s Syndrome
por: Haykal, Rasha, et al.
Publicado: (2020)

SUN-355 Computed Tomography Appearance of Adrenal Glands in Non-Adrenal Causes of Cushing's Syndrome
por: Bansal, Rashika, et al.
Publicado: (2019)

Assessment of Chronic Supraphysiological Glucocorticoid Dosing Needs of Patients With Adrenal Insufficiency
por: Mun, Jeff, et al.
Publicado: (2021)

A Re-Examination of the oCRH Stimulation Test for the Diagnosis of Ectopic ACTH Secretion
por: Newman, Andrew Joseph, et al.
Publicado: (2021)

The Improvement in Hepatic Steatosis After Cushing’s Syndrome Treatment Is an Early Sign of Metabolic Recovery
por: Hamimi, Ahmed, et al.
Publicado: (2021)

SAT320 Cyclic Cushing Syndrome Caused By An ACTH-Producing Pheochromocytoma
por: Omotosho, Yetunde Bernice, et al.
Publicado: (2023)

MON-444 Defining Remission In Cushing Syndrome After Tumor Resection In Cases Of Non-suppressed Postoperative Serum Cortisol Levels
por: McGlotten, Raven, et al.
Publicado: (2019)

THU039 Use Of Desmopressin In The Differential Diagnosis Of Cushing’s Syndrome: Recent Experience At The NIH
por: McGlotten, Raven, et al.
Publicado: (2023)

PMON102 Utility of the Desmopressin Stimulation Test to Detect Cyclic Cushing's Disease
por: Elenius, Henrik, et al.
Publicado: (2022)

PMON73 Lipid profile in patients with Cushing's syndrome and the impact of surgical treatment
por: Varghese, Ron, et al.
Publicado: (2022)

SAT-449 Factors Associated with Reduced Thyroid Hormones in Cushing Syndrome Patients Before and After Surgical Cure
por: Shekhar, Skand, et al.
Publicado: (2020)

MON-172 Comparison of a Late-night Salivary Cortisol Immunoassay and a Cortisol and Cortisone LCMS Assay in Patients with Cushing’s Disease
por: Kannankeril, Joshua, et al.
Publicado: (2020)

SAT-459 Hypothalamic-Pituitary-Gonadal (HPG) and Hypothalamic-Pituitary-Thyroid (HPT) Axes in Cushing Syndrome (CS): A Retrospective Cohort Study
por: Shekhar, Skand, et al.
Publicado: (2019)

MON-LB44 Cushing’s Syndrome and Illegal Receptors
por: Poku, Caroline, et al.
Publicado: (2020)

FRI099 Advanced Lipoprotein Analysis In Patients With Cushing’s Syndrome
por: Varghese, Ron T, et al.
Publicado: (2023)

MON-188 The Diagnostic Value of DHEAS in Subtyping Patients with Cushing Syndrome
por: Liu, Mengsi, et al.
Publicado: (2020)

MON-203 Aldosterone Biosynthesis Among Patients with Overt or Subclinical Cushing’s Syndrome
por: Inoue, Kosuke, et al.
Publicado: (2020)

MON-190 Telomere Length as a Novel Prognostic Marker of Cushing Complications
por: Tatsi, Christina, et al.
Publicado: (2020)

THU030 Evaluation Of Combined CRH And HDDST Test Performance
por: Elenius, Henrik, et al.
Publicado: (2023)

PSUN57 Noninvasive Assessment of the Coronary Artery Vessel Wall in Cushing's Syndrome Patients using 3-T Magnetic Resonance Imaging: Evidence for Increased Atherosclerosis Compared to Risk Matched Controls
por: Vaid, Sonal, et al.
Publicado: (2022)

MON-180 Risk for Hypercoagulability Among Patients with Cushing Syndrome. From the National Inpatient Sample
por: Ahmed, Fatima, et al.
Publicado: (2020)

MON-LB061 Cushing Syndrome Due to an Adrenocortical Carcinoma in a Baby with Atypical Beckwith-Wiedemann Syndrome
por: Bereket, Abdullah, et al.
Publicado: (2019)

MON-157 The Effect of Exogenous Cushing’s Syndrome on All-Cause and Cause-Specific Mortality: A Systematic Review
por: Limumpornpetch, Padiporn, et al.
Publicado: (2020)

OR28-6 Short-Term Mifepristone Treatment Improves Hepatic and Adipose Tissue Insulin Sensitivity in Overweight and Obese Subjects with Glucose Intolerance
por: Grewal, Shivraj, et al.
Publicado: (2019)

THU538 Use Of Multiple Functional And Structural Imaging Modalities Improves Detection Of Ectopic ACTH Tumors
por: Elenius, Henrik, et al.
Publicado: (2023)

MON-174 Circadian Misalignment of the 24-H Profiles of Melatonin and Cortisol in Adrenal Insufficiency
por: Darji, Monika, et al.
Publicado: (2020)

MON-LB039 Acute Paraneoplastic Cushing’s Syndrome in a Patient With Small Cell Lung Cancer and Co-Incidental Adrenal Adenoma: A Case Report
por: Gerhardt, Louisa Maria Sophie, et al.
Publicado: (2020)

MON-176 Discovery and Identification of Late Stage Selective Nonpeptide ACTH Antagonists for the Treatment of Cushing’s Disease, Ectopic ACTH Secreting Tumors, and Congenital Adrenal Hyperplasia
por: Kusnetzow, Ana Karin, et al.
Publicado: (2020)

MON-LB035 Adrenal Venous Sampling in the Lateralization of Acth-Independent Cushing Syndrome With Bilateral Adrenal Masses: A Case With a 5-Year Follow-Up
por: Kang, Yu Mi, et al.
Publicado: (2020)

SUN-333 Expression of Type 2 Somatostatin Receptors and Low Tumor Markers of Aggressiveness Correlate with Positive (68)Ga-DOTATATE Findings in Ectopic ACTH-Producing Tumors
por: Araque, Katherine, et al.
Publicado: (2019)

Cushing's syndrome, pheochromocytoma, or both?
por: Kullamaa, Liisa, et al.
Publicado: (2023)

MON-389 Normotensive Pheochromocytoma
por: Babli, Saleha, et al.
Publicado: (2019)

A Case of Iatrogenic Cushing’s Syndrome
por: Del Toro Diez, Andrea, et al.
Publicado: (2021)

Unusual Presentation of Cyclic Cushing’s Syndrome
por: Morales Hernandez, Maria del Mar, et al.
Publicado: (2021)

MON-169 Diagnostic Utility of Free Cortisol in Dexamethasone Suppression Test. A Prospective Study in Healthy Subjects
por: Athimulam, Shobana, et al.
Publicado: (2020)

MON-165 Utility of Salivary Cortisol After 1 Mg Oral Dexamethasone in the Evaluation of Incidental Adrenal Tumors
por: Arregger, Alejandro L, et al.
Publicado: (2020)

MON-393 Neuroblastoma Masquerading as Pheochromocytoma
por: Sultan, Rahaf, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_237i4hnmj30ooi4blt9dvfll9h